{
    "clinical_study": {
        "@rank": "100723", 
        "arm_group": {
            "arm_group_label": "Integrated sensor and infusion set.", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This is a multi-center, non-randomized, and interventional study in which subjects will use\n      the Integrated sensor and infusion set with MiniLink Transmitter and the Medtronic Paradigm\u00ae\n      VEO\u2122 insulin pump (Sensor augmented pump) for 15 days.\n\n      The purpose of this study is to collect performance data on the Integrated sensor and\n      infusion set for approximately 15 days, with the intention for each subject to wear 5 sets\n      for 3 days each."
        }, 
        "brief_title": "Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4", 
        "condition": [
            "Diabetes Mellitus Type I", 
            "Diabetes Mellitus Type II"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is 18 years of age or older at time of screening\n\n          -  Subject has a clinical diagnosis of insulin requiring diabetes, as determined by\n             investigator.\n\n          -  Subject is currently using a Medtronic Paradigm Sensor Augmented insulin pump and has\n             been so for a minimum of 3 months at time of enrollment.\n\n          -  Subject has Continuous Glucose Monitoring experience (min 30% of CGM use within the\n             month prior to enrollment).\n\n          -  Subject has an average of 3 SMBG per day (verified via CareLink) during the month\n             prior to enrollment.\n\n          -  Subject is willing to wear the study devices for the duration of the study\n\n          -  Subject is willing to perform frequent (min 7 per day) SMBGs during study device wear\n\n          -  Subject is willing to keep a short diary during the device wear.\n\n        Exclusion Criteria:\n\n          -  Female subject is pregnant, per urine pregnancy test performed at time of enrollment\n             in women of child bearing age.\n\n          -  Female subject plans to become pregnant during the course of the study.\n\n          -  Subject is unable to tolerate tape adhesive in the area of the placement of the study\n             device.\n\n          -  Subject has any unresolved adverse skin condition in the area of the placement of the\n             study device (e.g. psoriasis, rash, Staphylococcus infection).\n\n          -  The subject is not deemed to be an appropriate candidate for the study by the\n             investigator for any reason."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01775059", 
            "org_study_id": "CEP 277", 
            "secondary_id": "2012102304"
        }, 
        "intervention": {
            "arm_group_label": "Integrated sensor and infusion set.", 
            "intervention_name": "Integrated sensor and infusion set.", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 4, 2013", 
        "location": [
            {
                "contact": {
                    "email": "hans.gjessing@slb.regionsyddanmark.dk", 
                    "last_name": "Hans Gjessing, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Fredericia", 
                        "country": "Denmark", 
                        "zip": "7000"
                    }, 
                    "name": "Fredericia Hospital"
                }, 
                "investigator": {
                    "last_name": "Hans Gjessing, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ulrik.pedersen-bjergaard@regionh.dk", 
                    "last_name": "Ulrik Pedersen-Bjergaard, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Hilleroed", 
                        "country": "Denmark", 
                        "zip": "3400"
                    }, 
                    "name": "Hilleroed Hospital"
                }, 
                "investigator": {
                    "last_name": "Ulrik Pedersen-Bjergaard, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kirsten.noergaard@regionh.dk", 
                    "last_name": "Kirsten Norgaard, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Hvidovre", 
                        "country": "Denmark", 
                        "zip": "2650"
                    }, 
                    "name": "Hvidovre Hospital"
                }, 
                "investigator": {
                    "last_name": "Kirsten Noergaard, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "1", 
        "other_outcome": {
            "description": "MARD(%), BIAS(mg/dl), MAD(mg/dl) during study", 
            "measure": "Accuracy endpoint", 
            "safety_issue": "No", 
            "time_frame": "5 months"
        }, 
        "overall_contact": {
            "email": "ulrik.pedersen-bjergaard@regionh.dk", 
            "last_name": "Ulrik Pedersen-Bjergaard, MD"
        }, 
        "overall_official": {
            "affiliation": "Hilleroed Hospital", 
            "last_name": "Ulrik Pedersen-Bjergaard, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Health and Medicines Authority", 
                "Denmark: The Danish National Committee on Biomedical Research Ethics"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Agreement Rate (% within 20%) using VEO Pump", 
                "measure": "Accuracy endpoint", 
                "safety_issue": "No", 
                "time_frame": "5 months"
            }, 
            {
                "description": "Descriptive summary of SAE, Adverse events and Device complaints", 
                "measure": "Safety endpoint", 
                "safety_issue": "Yes", 
                "time_frame": "5 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01775059"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Agreement Rate (% within 20%) using re-analyzed Guardian\u00ae REAL-Time and Paradigm\u00ae REAL-Time algorithm data", 
            "measure": "Accuracy endpoint", 
            "safety_issue": "No", 
            "time_frame": "5 months"
        }, 
        "source": "Medtronic Diabetes R&D Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Diabetes R&D Denmark", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}